Table 1 Patient demographics and clinical characteristicsa
Disease | Sex (n) | Race (n) | Mean age, years (range) | Mean CLASI or CDASI score | Medications (patients, n) |
|---|---|---|---|---|---|
DLE (n = 21) | Females, 16 Males, 5 | AA, 12 White, 8 Hispanic, 1 | 45.0 (23 to 64) | 8 | Antimalarials, 18 Methotrexate, 2 Immunosuppressants, 5 Corticosteroids, 3 Dapsone, 1 Thalidomide, 1 |
SCLE (n = 10) | Females, 7 Males, 3 | White, 9 Asian, 1 | 47.1 (20 to 64) | 9.5 | Antimalarials, 7 Immunosuppressants, 2 Corticosteroids, 2 Thalidomide, 4 |
TLE (n = 10) | Females, 8 Males, 2 | AA, 1 White, 9 | 42.9 (25 to 57) | 10.1 | Antimalarials, 10 Methotrexate, 1 |
DM (n = 18) | Females, 15 Males, 3 | AA, 1 White, 16 Asian, 1 | 49 (21 to 75) | 14.7 | Antimalarials, 10 Methotrexate, 6 Immunosuppressants, 6 Corticosteroids, 9 |
controls (n = 18) | Females, 10 Males, 8 | AA, 4 White, 12 Asian, 2 | 31.2 (26 to 57) | N/A | N/A |